APA (7th ed.) Citation

AM, A., DE, B., B, H., B, B., & CY, B. (2020). Prognostic significance of pre- and post-treatment PD-L1 expression in patients with primary high-grade non-muscle-invasive bladder cancer treated with BCG immunotherapy. World journal of urology, 38(10), 2537. https://doi.org/10.1007/s00345-019-03065-2

Chicago Style (17th ed.) Citation

AM, Aydin, Baydar DE, Hazir B, Babaoglu B, and Bilen CY. "Prognostic Significance of Pre- and Post-treatment PD-L1 Expression in Patients with Primary High-grade Non-muscle-invasive Bladder Cancer Treated with BCG Immunotherapy." World Journal of Urology 38, no. 10 (2020): 2537. https://doi.org/10.1007/s00345-019-03065-2.

MLA (9th ed.) Citation

AM, Aydin, et al. "Prognostic Significance of Pre- and Post-treatment PD-L1 Expression in Patients with Primary High-grade Non-muscle-invasive Bladder Cancer Treated with BCG Immunotherapy." World Journal of Urology, vol. 38, no. 10, 2020, p. 2537, https://doi.org/10.1007/s00345-019-03065-2.